Van den Bosch, F <br/><br/>
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study.  [electronic resource] 

 -  Annals of the rheumatic diseases  Jun 2000 
 - 428-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-4967 
<br/><br/><label>Standard No.: </label>10.1136/ard.59.6.428  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Antibodies, Monoclonal--administration & dosage<br/>Arthritis, Psoriatic--drug therapy<br/>Drug Therapy, Combination<br/>Evaluation Studies as Topic<br/>Female<br/>Glucocorticoids--therapeutic use<br/>Humans<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Patient Selection<br/>Pilot Projects<br/>Prednisolone--therapeutic use<br/>Psoriasis--drug therapy<br/>Spondylitis--drug therapy<br/>Spondylitis, Ankylosing--drug therapy<br/>Statistics, Nonparametric<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--immunology